CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
For the period ended Jun 30, 2024. Filed Aug 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 9, 2024
CELZ$0.62+2.6%Stored close · as of Nov 6, 2026
Contents
Unaudited Condensed Consolidated Balance Sheets
| UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | ||
|---|---|---|
| June 30, 2024 | December 31, 2023 | |
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash | $7,471,476 | $3,466,867 |
| Investments | - | 6,520,191 |
| Inventory | 3,394 | 6,594 |
| Prepaids and other current assets | 129,086 | 277,246 |
| Total Current Assets | 7,603,956 | 10,270,898 |
| OTHER ASSETS | ||
| Other assets | 3,281 | 3,281 |
| Licenses, net of amortization | 382,469 | 441,011 |
| TOTAL ASSETS | $7,989,706 | $10,715,190 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $322,158 | $317,280 |
| Accrued expenses | 39,920 | 39,920 |
| Advances from related party | 14,194 | 14,194 |
| Total Current Liabilities | 376,272 | 371,394 |
| TOTAL LIABILITIES | 376,272 | 371,394 |
| STOCKHOLDERS' EQUITY | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized at June 30, 2024 and December 31, 2023 | - | - |
| Series B preferred stock, $0.001 par value, 1 share authorized, issued and outstanding at June 30, 2024 | 100 | - |
| Common stock, $0.001 par value, 5,000,000 and 50,000,000 shares authorized; 1,431,126 and 1,431,126 issued and 1,338,126 and 1,373,626 outstanding at June 30, 2024 and December 31, 2023, respectively | 1,431 | 1,431 |
| Additional paid-in capital | 69,730,073 | 69,711,749 |
| Accumulated deficit | (61,697,704) | (59,098,432) |
| Treasury stock, at cost, 93,000 and 57,500 shares as of June 30, 2024 and December 31, 2023 | (420,466) | (270,952) |
| 7,613,434 | 10,343,796 | |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| $7,989,706 | $10,715,190 | |
| The accompanying notes are an integral part of these condensed consolidated financial statements | ||
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.